E
Elicera Therapeutics AB
STO:ELIC
Elicera Therapeutics AB
STO:ELIC
Price:
5.59
SEK
-1.58%
Market Closed
Market Cap:
kr271.3m
Cash Flow Statement
Cash Flow Statement
Elicera Therapeutics AB
Elicera Therapeutics AB
Currency: SEK
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
(26)
|
(16)
|
(17)
|
(20)
|
(22)
|
(19)
|
(17)
|
(19)
|
(16)
|
(13)
|
(18)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
13
|
3
|
2
|
(2)
|
(6)
|
3
|
(7)
|
5
|
3
|
(2)
|
(4)
|
|
| Cash from Operating Activities |
(13)
N/A
|
(13)
-1%
|
(15)
-16%
|
(22)
-48%
|
(28)
-25%
|
(16)
+43%
|
(23)
-49%
|
(15)
+36%
|
(13)
+12%
|
(16)
-19%
|
(22)
-37%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
0%
|
0
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
21
|
20
|
20
|
20
|
20
|
20
|
20
|
22
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
21
N/A
|
20
-1%
|
20
N/A
|
20
N/A
|
20
-3%
|
20
+1%
|
20
N/A
|
20
N/A
|
|
| Change in Cash | ||||||||||||
| Net Change in Cash |
(12)
N/A
|
(12)
-1%
|
(14)
-16%
|
(1)
+93%
|
(7)
-572%
|
5
N/A
|
(3)
N/A
|
5
N/A
|
7
+37%
|
4
-37%
|
(2)
N/A
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(13)
N/A
|
(13)
-1%
|
(15)
-16%
|
(22)
-48%
|
(28)
-25%
|
(16)
+43%
|
(23)
-49%
|
(15)
+36%
|
(13)
+12%
|
(16)
-19%
|
(22)
-37%
|
|
Switch to:
Switch to:
See Also
Discover More
